AU Patent

AU2016291597B2 — Formulations for improving the efficacy of hydrophobic drugs

Assigned to Peptinovo Biopharma Inc · Expires 2021-01-14 · 5y expired

What this patent protects

Novel amphiphilic peptide, peptide amphiphile lipid micelles, processes for making peptide amphiphile lipid micelles comprising an amphiphilic peptide and phospholipid and optionally comprising a cargo molecule, and methods of use.

USPTO Abstract

Novel amphiphilic peptide, peptide amphiphile lipid micelles, processes for making peptide amphiphile lipid micelles comprising an amphiphilic peptide and phospholipid and optionally comprising a cargo molecule, and methods of use.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016291597B2
Jurisdiction
AU
Classification
—
Expires
2021-01-14
Drug substance claim
No
Drug product claim
No
Assignee
Peptinovo Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.